Verition Fund Management »

Jazz Pharmaceuticals shares owned by Verition Fund Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $350k 6.3k 55.90

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Eli Lilly & Co. (LLY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Warner Bros Discovery Com Ser A (WBD)
Norfolk Southern (NSC)
Cyberark Software SHS (CYBR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Verition Fund Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Dimensional Fund Advisors
Capital World Investors
LSV Asset Management
State Street Corporation
Jpmorgan Chase & Co
Ameriprise Financial
EcoR1 Capital
Hanna Zanoni
Geode Capital Management
GoldenTree Asset Management
Swedbank AB
Morgan Stanley
Citadel Advisors

View all funds holding Jazz Pharmaceuticals